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Neuroscience is a multidisciplinary endeavour that broadly connects across STEM 
disciplines as well as economics, marketing and law. This breadth has led to a global brain 
research race exemplified by several large-scale government-funded projects in recent years 
launched in Europe, the United States, Japan and China, to unravel the complexity of the 
nervous system in health and disease, and the application of this data to accelerate 
technological development (Poo et al., 2016). 
 
In contrast, most African governments do not give neuroscience the same level of attention.  
Indeed, Africa has a rich medicinal plant resource, placing the continent in a strong position 
in the area of drug discovery (Abegaz, 2016). Most of our today’s understanding of the brain 
comes from research performed in “The Global North”, with only minor contributions from 
Africa (Abd-Allah et al., 2016), where access to quality science education and infrastructure 
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remains difficult (Okeke et al., 2017). Research infrastructure is generally weak, funding 
levels minimal and teaching load on scientists enormous. Furthermore, suitable research 
equipment is typically lacking, in disrepair, or disused due to a lack of local expertise or 
surrounding basic infrastructure (Yusuf et al., 2014). For example, the lack of reliable power 
across large stretches of the continent continues to make it difficult to acquire, use or store 
common tools and consumables used in bioscience, thus hampering African-led scientific 
innovation. Likely as one result, Africa generated only 0.1% of the world’s patents in 2013 
(Baskaran, 2017).  
 
Some of these challenges have been targeted by local and international programmes 
focused on training African scientists and to set-up laboratories for cutting-edge research 
within Africa. In neuroscience, organisations like The International Brain Research 
Organisation (IBRO) or The International Society for Neurochemistry (ISN), among others, 
have focussed on supporting mostly young African neuroscientists to acquire further training 
within and outside Africa. Organisations like Teaching and Research in Natural Sciences for 
Development in Africa (TReND) (www.trendinafrica.org) or Seeding labs 
(https://seedinglabs.org) in addition facilitate equipment donations to boost laboratory 
infrastructure within Africa, or lead scientist-volunteer exchange programmes (for a detailed 
review see (Karikari et al., 2016)).  Together, these types of efforts have likely contributed to 
an increased interest in neuroscience among African scientists in the recent past. 
 
In Nigeria, Africa’s most populous nation, neuroscience is now a popular career option for 
many aspiring scientists, as perhaps best exemplified by the high number of Nigerians 
attending African neuroscience summer schools and meetings (typically, about half of all 
African applications come from Nigeria). Indeed, a recent estimate placed Nigeria as the 
third hotspot for neuroscience research in Africa, following South Africa and Egypt (Abd-
Allah et al., 2016). Database mining efforts estimated a total of 1,079 neuroscience 
publications affiliated with Nigeria between 2003 to 2013 (Abd-Allah et al., 2016) and 1,774 
between 1997 – 2017 (Balogun et al., 2017). However, from here it is difficult to quantify the 
specific contribution of Nigerian laboratories to these publications. Common search 
strategies rarely differentiate between studies that were truly driven from within Africa and 
studies driven by Africans abroad, foreign laboratories merely affiliated with African 
institutions or even non-African led research conducted on African populations. For example, 
68.7% of publications from Sub-Saharan Africa in 2014 had non-African co-authors 
(Baskaran, 2017), which leaves unclear as to what extent the experimental work presented 
in these publications has been conducted within the continent.  
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To source reliable data about Africa’s true scientific output, we therefore present here a 
strategy to extract and analyse publications specifically driven by researchers within Africa 
and trial our approach on Nigerian neuroscience output over the past 2 decades. We hope 
that the resultant dataset will enable existing African research institutions to assess their 
strategies and scientists to evaluate the impact of their work, and inform governments and 
funders on the strengths and weakness of neuroscience research in different regions of the 
continent and thus enable the development of programmes focussed on the specific need of 
neuroscience researchers in the region.  For instance, it is not clear to what extent powerful 
and more affordable research models such as fruit flies, zebrafish, C. elegans or genetically 
modified cell cultures have been adopted in African research. To therefore establish and test 
a framework for evaluating neuroscience output from the continent as a whole, we here 
extracted PubMed-indexed Nigerian neuroscience publications from 1996 to 2017 and 
manually extracted articles following stringent criteria that specifically identify articles from 
Nigerian laboratories (Table 1). From here, we categorised them into either basic or clinical 
and epidemiological research, and analysed each for overall direction, research models and 
techniques used and citation metrics.  
 
 
The strategy used to assess the Neuroscience research output from Nigeria  
 
Using PubMed search, we retrieved 1,247 neuroscience publications from Nigeria between 
1996 – 2017. In contrast, the same search terms entered into Dimensions 
(https://www.dimensions.ai/) returned 340,338 publications, while 693 articles were retrieved 
for 1996 – 2017 according to Scimago (https://www.scimagojr.com/). In view of this striking 
variability between search engines, it is difficult to assess the “true” number of Nigerian-led 
neuroscience publications. However, in view of PubMed’s leading role in indexing scientific 
publications, we think that most internationally important Nigerian led-studies would be 
captured in our sample. Therefore, the articles retrieved from PubMed were further reviewed 
for duplicates and unrelated articles, reducing them down to 990 articles. Next, to specifically 
identify Nigerian-led articles we retrieved full texts of all articles for further analysis according 
to defined includion and exclusion criteria (Table 1). Application of these criteria reduced 
articles down to a final set 572. For the compilation of techniques in studies conducted in 
collaboration with a centre outside Nigeria, only the techniques used in Nigeria were 
collected.  
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Next, manual scoring (Fig. 1A, Methods) revealed that only about half of the PubMed 
identified publications (n=572, 54%) were primarily driven by Nigerian laboratories. From 
here, we categorised each remaining article as either basic research (“Basic”, n=255, 
45.5%) or “clinical and epidemiological” research (“Clinical”, n=318, 55.5%) based on the 
criteria for types of studies in medical research (Röhrig et al., 2009). This numerical 
dominance of clinical over basic research output is consistent with previous studies (Abd-
Allah et al., 2016). However, as discussed below, basic research on average scored 
significantly higher than clinical and epidemiological work when comparing citations and 
journal impact factors. 
 
 
Neuroscience publication trend in Nigeria  
 
Between 1996 and 2017, annual numbers of publications gradually increased, with initially a 
larger number of clinical papers published each year (Fig. 1B). However, since 2012/13, the 
number of basic and clinical studies were on par, with both showing a striking increase after 
~2013 that was particularly pronounced for basic research. Together with the recent and 
ongoing increase in the number of neuroscientists in Nigeria, trained locally and abroad, this 
suggests that the annual number of Nigeria’s neuroscience publications may continue to 
exponentially rise in the near future. Since 2000, basic neuroscience studies were 
consistently more cited than clinical studies (Fig. 1C). 
 
 
Popular journals for neuroscience publication in Nigeria 
 
Next, we evaluated the types of journals used and their impact factors (IF, Fig. 2). There are 
many shortfalls in focusing on journal IF to evaluate research influence. However, Nigeria’s 
science generally lacks visibility. Most local journals, including The journal of the Nigerian 
Society of Neuroscience itself (http://www.neurosciencenigeria.org/journal-articles/)  are not 
yet indexed in online databases. We find that across both basic and clinical neuroscience, 
most articles were published in either “low” (IF 0-1, 42%) or “mid-tier” (IF 1-4, 55%) journals, 
with only 18 papers (3%) ranking higher. The highest IF publication appeared in “Movement 
Disorders” (IF 8.324). Accordingly, while there is clear evidence of steady publication output 
in reputable international journals, across the more than two decades investigated, only one 
Nigerian-led neuroscience papers was published in a journal with IF above 8.  
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Next, basic research scored consistently higher on both citations per paper and journal IF 
(Fig. 2A-C). For example, while most clinical studies were published in journals with IF below 
1 (57%), most basic studies fell into the IF 1-4 bracket (75%). Overall, 142 papers (25%) 
were published in 21 different African journals which all had an IF below 1 (Fig. 2D). These 
142 articles were mostly clinical articles (82%), with comparatively few basic research 
articles (18%). Instead, most basic research articles (90%) were published in 243 (92%) 
different non-African journals (Fig. 2D,E). Even though by numbers applied neuroscience 
research dominates in Africa (Abd-Allah et al., 2016), these publication and citation trends 
indicate an overall strength in basic rather than applied neuroscience research in the region. 
To improve the research visibility of Nigerian science, the Nigerian National University 
Commission (NUC) which is responsible for regulating universities in Nigeria, has in recent 
times organised workshops for academics to encourage publishing in high impact journals 
worldwide. 
 
 
 
Model systems, techniques and research on medicinal plants  
 
Fruit flies, zebrafish and C. elegans are powerful model organisms in biological and 
biomedical research used in the West due to their many advantages such as relatively short 
generation time, genetic tractability and affordability (Clovis, 2017). In contrast, these model 
organisms were wholly absent from Nigerian neuroscience publications over the 21 year 
period, nor was there any use of genetically modified mammalian systems  (Fig. 3A). 
Instead, wild-type rat (64%) and mouse models (23%) dominated basic research, followed 
mainly by other non-genetically modified mammals (Fig. 3A). In other words, research using 
genetically modified models appears to be completely absent from the Nigerian 
neuroscience research output over the 2 decades surveyed.    
 
 
 
 
 
Model systems aside, a further striking problem concerned the types of research techniques 
employed in Nigerian neuroscience laboratories. Many key “advanced” methods available to 
researchers outside Africa, such as cell culture, PCR and qPCR, western blotting, 
fluorescence and electron microscopy, among others, are rarely available in African 
laboratories. In Nigeria, researchers commonly use histological techniques such as 
“standard” hematoxylin and eosin staining (H&E) for microscopic examination, enzyme-
linked immunosorbent assay (ELISA) and high-performance liquid chromatography (HPLC) 
for enzymatic/hormonal analysis and morphological examinations to assess gross 
abnormalities or rodent behavioural analysis to investigate changes to learning and memory 
(Fig. 3B). We accordingly categorised the methods reported in the Nigerian basic 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
neuroscience publications into “standard” and “advanced” (Fig. 3B, Table 1). This revealed 
that only 8% of basic neuroscience studies used any “advanced” methods (Fig. 3C). 
 
Next, across Africa medicinal plants have been used for centuries to treat disease. As a 
consequence, much local research has been devoted to understanding their effectiveness, 
mechanisms of action, isolation of components adaptable for drug production or eventual 
use in clinical trials (Tang et al., 2017, Ntie-Kang et al., 2014, Shang et al., 2007). In 
agreement, 41% of all basic neuroscience publications examined set-out to test the utility of 
medicinal plants for future medical application (Fig. 3D). In particular, most studies assessed 
the antioxidant and anticonvulsant activity of candidate plant extracts (Fig. 3E, 
Supplementary material). Out of these studies, 89% reported that the medicinal plant 
extracts were effective, while the remaining 11% were reported to be either ineffective or 
toxic (Fig. 3E). Based on these reults, it might be expected that this would at times translate 
into clinical research. However, strikingly, zero clinical studies or case report involved the 
use of medicinal plants, suggesting that the results from basic science were not taken 
towards eventual patient care. This disconnect between basic and clinical research may 
have many causes. Perhaps most importantly, while many studies explored the effects of 
plant extracts on rodent behaviour and induced pathology, these studies rarely went on to 
actually isolate potential active compounds for further study. This issue is likely linked to the 
near complete absence of research infrastructure and expertise in “advanced” research 
methods. Nonetheless, basic neuroscience studies that used medicinal plants were 
significantly more cited and were on average published in higher IF journals compared to 
other basic neuroscience publications at the same time (Fig. 3F).  
 
 
Neuroscience hotspots in Nigeria 
 
Nigeria is host to more than 100 universities and polytechiques, with many harbouring active 
research departments. To identify neuroscience hotspots in the country we further analysed 
all institutions with at least ten neuroscience publications (basic and clinical summed) over 
the analysed 21 year period. We compared mean publication numbers and citations (Fig. 4). 
This revealed that the University of Ibadan, the oldest in the country, produced the largest 
number of neuroscience publications (165). However, publications from other universities 
were more cited. For example, the “only” 10 publications from the National Institute for 
Pharmaceutical Research and Development Abuja (NIPRD) were on average cited three 
times more frequently (Fig. 4B). Notably, all publications from NIPRD were basic research, in 
comparison to only 37% of articles from the University of Ibadan (cf. Fig. 2), which may be 
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linked to some of this difference. Interestingly, all these institutions have at least one 
publication in which an advanced technique was used locally, except NIPRD and University 
of Nigeria, Nsukka (UNN), implying that most Nigerian research institutions have at least 
partial access to more modern research infrastructure, if only sproradically so. Overall, this 
highlights some of the top institutions engaged in neuroscience research in Nigeria. 
However, it is possible that other institutions in the country did not make it to the list because 
they published in journals that were not indexed or their articles failed the criteria used in this 
study. All data that contributed to this study is available in the Supplement. 
 
 
Discussion 
 
The number of Nigeria’s neuroscience publications has seen a speedy increase since 2000. 
This could be attributed to increased support from international organisation towards 
education in the country that peaked in the early 2000s (Ogunyinka, 2013), the political will 
to invest in education that started with the return of democracy (Chinyere and Goodluck, 
2015), or the slow implementation of Education Tax Act since the 1990s and the re-
introduction of new acts, such as the Tertiary Education Trust Fund (TETFund) Act in 2011 
that is currently the main source of research fund in the country 
(http://www.tetfund.gov.ng/index.php/about-us/history). The neuroscience society of Nigeria 
(http://www.neurosciencenigeria.org/) currently has over 200 members, some of whom are 
currently pursuing higher degrees in neuroscience-related disciplines within and outside 
Nigeria, suggesting that the annual number of Nigeria’s neuroscience publications may 
continue to exponentially rise in the near future. 
 
Although there is a clear evidence of a solid neuroscience research base and steady 
publication output in reputable international journals, across the nearly two decades 
investigated, only one Nigerian-led neuroscience paper was published in a “top-tier” journal. 
Moreover, clinical papers tend to be mostly published in African journals, which typically 
have poor international visibility and a correspondingly low IF. Indeed, most African journals 
are not PubMed indexed, which again likely results in poor access and visibility of African 
research on the global stage (Goehl and Flanagin, 2008). This is also worrying because it 
limits the extent to which African-specific clinical problems can be identified and addressed 
in the global research community. It also limits the extent to which local basic research 
questions can be sparked by clinical findings. Overall, and under the explicit caveat of using 
IF and citations as problem-ridden impact metrics (Aragón, 2013, Hutchins et al., 2016),  
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Nigeria’s neuroscience publication and citation trends indicate an overall strength in basic 
rather than applied neuroscience research in the region. 
 
Another striking finding is the complete absence of popular model systems like zebrafish, 
fruit flies or C. elegans, which are cheaper and genetically tractable compared to many 
mammalian models. Indeed, of Nobel Prizes in Physiology and Medicine awarded between 
1996 and 2017, one third relied heavily on non-mammalian yet genetically accessible model 
species. Many of the specific challenges facing African researchers (e.g. low research 
funding, unreliable power) would make the oftentimes “more hardy” and low-cost models 
such as Drosophila ideal for research on the continent. In fact, like humans, evolutionary 
history places the origins of Drosophilids on the African continent (Keller, 2007). 
Encouragingly, 2018 actually did see the possibly first Drosophila neuroscience paper 
published by an all-Nigerian lab (Akinyemi et al., 2018), perhaps hinting at a future turn of 
the tide in the use of model species in the region. Taken together, this in particular calls for 
increased investment to facilitate the use of small, genetically amenable and affordable 
model species in African laboratories, as championed by a number of international 
organisations (e.g. TReND in Africa www.TReNDinAfrica.org or DrosAfrica 
http://drosafrica.org/). 
 
Another striking problem concerned the types of research techniques employed in Nigerian 
neuroscience laboratories. Out of the 8% of basic neuroscience studies in which advanced 
techniques were used, none included techniques like western blotting, PCR, or advanced 
microscopic approaches. Indeed, to the authors’ knowledge there is currently no functional 
transmission electron microscope or confocal microscope in Nigeria (although there are a 
handful of operational confocal microscopes on the continent, including to the author’s 
knowledge ones in research institutions in Ghana, Kenya, Tanzania and South Africa). 
Furthermore, laboratory consumables such as antibodies are difficult to procure and when 
available, difficult to store due to unreliable power. Moreover, many scientists lack technical 
training or experience in the use of key modern neuroscience methods. As a result, Nigerian 
scientists often fly to non-African laboratories e.g. with paraffin blocks to conduct their work 
in better-equipped conditions abroad, and many talented scientists end up staying. 
Publication in the world’s “top” journals typically requires interdisciplinary approaches and 
state-of-the-art techniques. Here, Nigerian neuroscience studies are likely not making it into 
these journals in part due to the general absence of advanced neuroscience techniques in 
Nigerian laboratories, and in part due to poor international visibility of their preceding work. 
Our findings demonstrate an urgent need for an increase in local research funding and 
training in state-of-the-art techniques to modernise Nigerian research infrastructure. In 
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addition, only few local or international training schemes in the region have focussed on the 
introduction of more modern neuroscience research techniques, with many instead 
bolstering competence in existing research technique (e.g. behaviour, histology etc.). 
Although recent funding initiatives by local (e.g. TETFund) and international (e.g. ISN, IBRO, 
The World Academy of Sciences) sources has led dozens of Nigerians to acquire modern 
neuroscience skills in foreign laboratories, the absence of biomedical research infrastructure 
locally in Nigeria further restrict to which extent trained scientists put their skills in into 
practice.  
  
Next, Nigeria has a rich pool of medicinal plants which if utilised could make the country a 
global hub for drug discovery. However, currently the complete absence of clinical studies 
using medicinal plants investigated in basic research towards eventual patient care is 
striking. In addition to the need for improved research infrastructure, this indicates a need for 
increased local collaboration between basic and clinical scientists to increase translational 
research opportunities. All research models used to study the medicinal plants were all wild-
type mammalian species, this reiterates the need for Nigerian laboratories to consider 
genetically accessible models in their research, which include numerous established disease 
models. For example, using Drosophila models for Epilepsy or Alzheimer’s Disease, 
researchers could screen for the ameliorative effects of medicinal plants against such 
diseases. 
 
In summary, even though Nigeria is among the hotspots of neuroscience on the African 
continent, here we argue that for Nigerian neuroscience to reach a global impact, several 
core issues must be addressed. In particular, two clear access points for the support of 
Nigerian neuroscience in the future stand out: Investment in the sustained training and 
infrastructure in the use of more modern research techniques, and the widespread 
promotion of genetically amenable model species. Moreover, any such effort might consider 
specifically targeting existing basic over clinical or epidemiological research efforts. Clearly, 
Nigerian laboratories must be improved through the funding for equipment, equipment 
donations and, critically, extensive and sustained training of local scientists in the use and 
management of these equipment. Otherwise, Nigeria will continue to lose its talent to 
developed nations. 
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Figure 1. Study design and publication trends. A, Workflow of publication retrieval and 
sorting strategy. B, Total publication per year for clinical (green) and basic research (black). 
C, Mean citations per annum. 
 
Figure 2. Citations and journal metrics for Nigerian neuroscience publications. A, 
Journal impact factor (IF) parallels paper citations over the period studied. B, C, Journals 
publishing basic (B) and clinical neuroscience articles (C). # indicates journals in which both 
basic and clinical papers were published. D, Percentage of African and non-African journals 
(grey) and percentage articles they published (blue). E, Percentage and mean citation of 
basic and clinical papers in African and non-African journals. African journals: p > 0.05; Non-
African journals: p = 0. 0.04. Mann–Whitney U test. Errorbars in SEM.    
 
Figure 3. Model systems, techniques and medicinal plants. A, Model systems used in 
basic and clinical research. B, Standard and advanced techniques used in Nigerian 
neuroscience. C, Techniques used in basic neuroscience. D, Articles studying medicinal 
plants. E, Research questions of studying medicinal plants. F, Outcome from studies 
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conducted to evaluate the effectives of medicinal plants. G, Violin plot of mean citations 
depending on medicinal plant usage (Mann–Whitney U test p = 0.0001, Error bars in SEM). 
*other models include cat, cattle, cell culture (not genetically modified), Egg yolk, goat, 
pangolin and guinea pig.  
 
Figure 4. Neuroscience hotspots in Nigeria. A, Top institutions engaged in neuroscience 
research based on total publications over the whole period surveyed. * Indicates institutions 
whose publications has no evidence of local use of advanced technique. B, Top institutions 
based on average article citation over the period surveyed. OAU – Obafemi Awolowo 
University; ABU – Ahmadu Bello University; UDUS – Usman Danfodiyo University; FUTA 
Federal University of Technology Akure; ABUAD - Afe Babalola University; LSU – Lagos 
State University; OOU – Olabisi Onabanjo University; UNICAL – University of Calabar; 
Unimad – University of Maiduguri; NIPRD - National Institute for Pharmaceutical Research 
and Development Abuja; UNN - University of Nigeria, Nsukka; UniAbuja – University of 
Abuja. 
 
 
Exclusion 
Articles with external collaboration where only a minor fraction of the work was conducted 
within Nigeria, such as plant extract collection. Articles with external collaborators in which 
study location was unclear. Research conducted by Nigerians (or on Nigerians) outside 
Nigeria. 
Inclusion 
Studies conducted in Nigeria and articles that investigate aspects of the nervous system, 
even if the focus was not neuroscience 
Advanced Techniques (for Africa) 
Electron microscopy, western blotting, immunohistochemistry, cell culture techniques, 
cloning, flow cytometry, fluorescence (confocal) microscopy, whole brain imaging, 
sequencing and identifying genes of interest, molecular cloning and recombinant DNA 
technology, gene delivery strategies, making and using transgenic organisms, 
manipulating endogenous genes etc. (Strickland, 2014). 
Standard Techniques 
Histology, Biochemical Assays, e.g. Enzyme-linked immunosorbent assay (ELISA), 
extract preparation, High-performance liquid chromatography (HPLC), behavioural 
analysis, blood analysis, craniometric analysis etc.  
 
Table 1. Article selection criteria. 
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